This list is based on the watchlists of people on Stock Events who follow LIPUM.ST. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.
Show more...
FAQ
What is Lipum AB stock price today?▼
The current price of LIPUM.ST is SEK14.35 SEK — it has increased by +0.7% in the past 24 hours. Watch Lipum AB stock price performance more closely on the chart.
What is Lipum AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lipum AB stocks are traded under the ticker LIPUM.ST.
What is Lipum AB market cap?▼
Today Lipum AB has the market capitalization of 304.39M
When is the next Lipum AB earnings date?▼
Lipum AB is going to release the next earnings report on April 28, 2026.
What is Lipum AB revenue for the last year?▼
Lipum AB revenue for the last year amounts to 0 SEK.
What is Lipum AB net income for the last year?▼
LIPUM.ST net income for the last year is -111.03M SEK.
How many employees does Lipum AB have?▼
As of April 02, 2026, the company has 6 employees.
In which sector is Lipum AB located?▼
Lipum AB operates in the Health Care sector.
When did Lipum AB complete a stock split?▼
Lipum AB has not had any recent stock splits.
Where is Lipum AB headquartered?▼
Lipum AB is headquartered in Umeå, SE.